Clinical Trials Directory

Trials / Conditions / Pharmacokinetics of Mirabegron

Pharmacokinetics of Mirabegron

11 registered clinical trials studyying Pharmacokinetics of Mirabegron.

StatusTrialSponsorPhase
TerminatedA Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive B
NCT04641975
Astellas Pharma Global Development, Inc.Phase 3
CompletedA Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants
NCT04501640
Astellas Pharma China, Inc.Phase 4
CompletedA Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorpti
NCT02211846
Astellas Pharma IncPhase 1
CompletedStudy of the Effect of Food on the Pharmacokinetics of Mirabegron
NCT00939757
Astellas Pharma IncPhase 1
CompletedPharmacokinetics of Oral Mirabegron With Different Release Rates Versus Intravenous (IV) Mirabegron
NCT00940121
Astellas Pharma IncPhase 1
CompletedA Study to Evaluate How Mirabegron Enters and Leaves the Bloodstream According to Age and Sex
NCT01285596
Astellas Pharma IncPhase 1
CompletedA Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin Simulta
NCT01297192
Astellas Pharma IncPhase 1
CompletedTo Evaluate the Effect of Mirabegron (YM178) on Blood Levels of Desipramine When They Are Taken Together
NCT01478568
Astellas Pharma IncPhase 1
CompletedA Study to Evaluate the Possible Effects of Taking Mirabegron While Taking a Contraceptive Pill
NCT01297179
Astellas Pharma IncPhase 1
CompletedA Study to Find Out How Much Mirabegron Gets Into the Body After Dosing With a Tablet Formulation
NCT01478529
Astellas Pharma IncPhase 1
CompletedTo Compare Blood and Urine Concentrations of Mirabegron (YM178) in Healthy Poor or Extensive Metabolizers for
NCT01478490
Astellas Pharma IncPhase 1